Introduction
European equity markets offer a genuinely distinct investment opportunity from the US-centric global portfolios that many internationally mobile investors accumulate by default. Europe's listed companies include world leaders in luxury goods, industrial equipment, speciality chemicals, pharmaceutical innovation, financial services and consumer brands. European equities have traded at historically large valuation discounts to US equivalents for much of the past decade — a discount that creates either a structural opportunity or a reflection of genuine structural inferiority, depending on one's view of the European economy's direction of travel.
For UK-based and UK-connected investors, post-Brexit changes have altered the mechanics of accessing European equity markets and the regulatory context for EU investment product access. This guide covers both the investment case and the practical landscape for European equity allocation as of 2026.
The Investment Case: Why European Equities Deserve Attention
Valuation
As of 2026, European equities — measured by MSCI Europe — trade at price-to-earnings ratios in the range of 13–15x forward earnings, compared with 20–22x for the S&P 500 on equivalent measures. This gap is partially justified by structural differences (lower technology weight in Europe, more cyclical and financial sector exposure) but partially reflects sentiment-driven underweighting by global investors.
Historical evidence suggests that buying quality at a valuation discount to its long-run average is a reliable predictor of superior forward returns over 5–10 year periods. Europe's discount, on multiple metrics, is now at historically extreme levels versus the US — which does not guarantee convergence but does strengthen the risk/reward case.
Sector Composition Strengths
Where Europe genuinely excels:
Luxury goods and premium consumer brands: LVMH, Hermès, Richemont, Kering, Ferrari, Moncler and their ecosystem of supplier companies represent a globally unique cluster of pricing-power businesses. These are not merely European companies — they serve wealthy consumers globally and are genuinely scarce competitive assets.
Industrial excellence: Siemens, ASML, Schneider Electric, Atlas Copco, Volvo, Sandvik, Kingspan. Europe's engineering heritage produces global leaders in automation, industrial software, precision manufacturing and building technology. These businesses have high ROIC, global market leadership and are critical to manufacturing modernisation and energy efficiency globally.
Healthcare and pharmaceuticals: Novo Nordisk (Denmark), AstraZeneca (UK), Novartis and Roche (Switzerland), Lonza, Bayer. European pharmaceutical companies have produced several of the most important drug developments of the 2020s, including GLP-1 receptor agonists for obesity and metabolic disease, which represent some of the largest commercial opportunities in pharmaceutical history.
Speciality chemicals: BASF, DSM-Firmenich, Evonik, Lanxess, Solvay. Chemical innovation drives materials development for semiconductors, batteries, food systems and healthcare.
Financial services: Major European banks (BNP Paribas, Deutsche Bank post-restructuring, BBVA, ING, Nordea) trade at discounts to US banking peers despite improving capital ratios and profitability. European insurance groups (Allianz, AXA, Munich Re, Swiss Re) are globally competitive.
Dividend Yield
European equities have historically offered higher dividend yields than US equivalents — 3–4% average yield versus 1.5–2% for the S&P 500 as of 2026. This income component is meaningful for HNW investors seeking portfolio income without heavy reliance on fixed income.
Structural Challenges
Honesty requires acknowledging the genuine structural headwinds:
German industrial malaise. Germany, Europe's largest economy and most important manufacturing hub, faces significant structural challenges: energy cost disadvantages following the 2021–2022 energy shock, Chinese competition in core industrial end-markets (particularly automotive), and sluggish domestic investment relative to the transition requirements. German equities require particularly careful sector and company-level selection.
Energy competitiveness. European industrial energy costs remain structurally higher than in the US (where shale gas provides cheap feedstock) or China. This is a long-run competitive disadvantage for energy-intensive industries.
Defence and security spending. Europe's commitment to materially increase defence spending — accelerated by the Russia-Ukraine conflict — is a tailwind for European defence companies (BAE Systems, Leonardo, Rheinmetall, Saab, Thales, Airbus) and represents a multi-year capital cycle that has received insufficient equity market attention.
Population and demographics. Southern European demographics are challenging; Eastern European demographic outflows create labour market pressures. These are long-term growth drags.
Regulatory burden and capital markets fragmentation. The EU single market is still imperfect; capital markets fragmentation relative to the US continues to disadvantage European companies seeking equity capital and results in US equivalents being valued more richly.
Post-Brexit Landscape for UK Investors
Brexit created specific considerations for UK-based investors accessing European markets:
EU Passporting Loss for UK Investment Products
UK UCITS funds lost EU passporting rights after Brexit. UK investors can still buy UCITS funds domiciled in Ireland, Luxembourg and other EU jurisdictions — and these remain the most appropriate structures for EU-resident investors. Most major asset managers maintain parallel UK-domiciled OEIC structures and EU-domiciled UCITS structures, allowing seamless access from both sides.
London Stock Exchange Access to European Shares
UK investors can access many European company shares directly through the London Stock Exchange (in sterling), through CREST settlement, or through UK-domiciled ETFs tracking European indices. Direct trading on Euronext Paris, Xetra (Germany), Euronext Amsterdam and other continental exchanges is also accessible through most UK brokers.
Swiss Equity Access
Switzerland is not in the EU, and Swiss-EU share trading relations have had their own complexities. Swiss equities (Nestlé, Novartis, Roche, ABB, UBS) are separately accessible through LSE or directly through Swiss Exchange; no Brexit-specific impediments apply.
Tax Treaty Landscape
Withholding taxes on European dividends remain the primary tax management issue for UK investors. Standard treaties apply: France imposes 12.8% withholding on UK investors (reduced from 30% under the France-UK treaty); Germany imposes 15%; Switzerland 35% with a partial refund mechanism. These are unchanged by Brexit.
Currency Considerations
European equity returns for sterling-based investors depend heavily on EUR/GBP and CHF/GBP dynamics:
- Sterling has historically been a cyclical currency, strengthening in global risk-on environments and weakening in risk-off periods.
- Euro has been the weak partner over 2022–2026, creating relative valuation support for European assets when translated back to sterling.
- Currency hedging EUR equity exposure for GBP-based investors is feasible (via UCITS hedged share classes or currency overlay) but adds cost of approximately 0.5–1.5% per annum depending on forward rate differentials.
An unhedged European equity position is a combined bet on European company performance and EUR appreciation. Investors should be clear which element of the bet they are making.
Implementation
Core passive allocation: iShares MSCI Europe, Vanguard FTSE Developed Europe All Cap — TERs 0.10–0.20%. Efficient base exposure including the UK (depending on index).
Ex-UK European: MSCI Europe ex-UK indices exclude British companies for investors who already have dedicated UK equity exposure.
Active specialist funds: Managers focused on European quality (quality growth in luxury, industrial technology, pharmaceutical themes) and European value (financial sector turnaround, industrial restructuring) have both produced differentiated returns versus the passive index.
Single-country ETFs: For targeted country bets (German industrial recovery, French quality growth), single-country UCITS ETFs are available.
How Global Investments Can Help
Global Investments maintains a specific European equity research capability and manages European equity allocations as part of broader global equity mandates for internationally mobile HNW clients. We can help you assess whether your current European exposure appropriately captures the sector strengths of the region — without over-weighting the structural challenges — and manage the currency and withholding tax dimensions of European equity ownership.
Contact our investment team to discuss European equity allocation within your global portfolio.
Capital is at risk. Currency movements may increase or decrease returns. European equity markets can experience significant volatility. The value of investments can fall as well as rise. This guide does not constitute personalised investment advice. Seek independent advice appropriate to your circumstances.
This guide is for general information only and does not constitute financial advice or a personal recommendation. The value of investments can fall as well as rise and you may get back less than you invest. Past performance is not a guide to future returns. Tax rules, investment regulations, and the availability of specific investment vehicles change — always verify current rules and seek advice from a qualified independent financial adviser before making any investment decisions.